Differential risk of Parkinsons disease according to diabetes treatments: A cohort study

Oct-20

Endocrinology Neurology Pharmacoepidemiology

AUTHORS : Dr Ruth Brauer, Research Department of Practice and Policy, UCL School of Pharmacy, Mezzanine Floor, BMA House, Entrance A, Tavistock Square, London WC1H 9JP, United Kingdom – Email: r.brauer@ucl.ac.uk – Profile: https://iris.ucl.ac.uk/iris/browse/profile?upi=RBRAU10

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 29(S3):58-59

DOI : 10.1002/pds.5114

Differential risk of Parkinsons disease according to diabetes treatments: A cohort study

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study